HCM Q1 2019 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$52M-0.3% YoY

Gross Profit

$11M21.5% margin

Operating Income

-$36M-69.1% margin

Net Income

-$20M-38.1% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-55.0%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$539M

Total Liabilities

$139M

Stockholders' Equity

$376M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$52M	-0.3%
Gross Profit	$11M	$15M	-26.6%
Operating Income	-$36M	-$25M	-44.1%
Net Income	-$20M	-$12M	-69.5%